Selectis Health CFO Brandon Thall resigns; Controller Christine Lucus named interim CFO

SELECTIS HEALTH, INC.

Brandon Thall resigned as CFO effective March 4, 2022; immediate departure.
Christine Lucus, former Controller, appointed interim CFO effective March 4, 2022.
Lucus base salary $135,000/year; eligible for $15,000 bonus for timely SEC filings.
Lucus previously Controller at Neubase Therapeutics (NASDAQ) and has 7 years experience.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brandon Thall

Chief Financial Officer

GBCS · SELECTIS HEALTH, INC.

Effective: 2022-03-04
Successor: Christine Lucus
Filed: March 9, 2022, 6:59 PM ET

Mr. Brandon Thall tendered his resignation as Chief Financial Officer of Selectis Health, Inc.

Appointed (interim)

Christine Lucus

interim Chief Financial Officer

GBCS · SELECTIS HEALTH, INC.

Effective: 2022-03-04
Filed: March 9, 2022, 6:59 PM ET

Christine Lucus, formerly serving as Controller, has been appointed interim CFO of the Company effective March 4, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brandon Thall resigned as Chief Financial Officer at SELECTIS HEALTH, INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Mr. Brandon Thall tendered his resignation as Chief Financial Officer of Selectis Health, Inc.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Christine Lucus was appointed as interim Chief Financial Officer at SELECTIS HEALTH, INC..

Action: appointed
Role: interim Chief Financial Officer

Exact text from the filing

Christine Lucus, formerly serving as Controller, has been appointed interim CFO of the Company effective March 4, 2022.

View on SEC.gov

SELECTIS HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001493152-22-006350

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.